Form 4 for AORT ARTIVION, INC.

Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-23 · accession 0000784199-24-000059 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-02-28	2024-02-26	AORT	Stanton Marshall S.	SVP, Clinical, MD Affair	S - Sale	$20.27	-3,048	72.5K	-4%	-$61.8K
M	2024-02-28	2024-02-23	AORT	Stanton Marshall S.	SVP, Clinical, MD Affair	A - Grant	$0.00	+16.0K	74.1K	+28%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-26	S	D	1,448	$20.27	81,685	D	—	—	(F2) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
2	Common	Common Stock	2024-02-23	A	A	10,644	$0.00	83,133	D	—	—	(F3) Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date
3	Common	Common Stock	2024-02-23	A	A	5,386	$0.00	74,089	D	—	—	(F1) Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
4	Common	Common Stock	2024-02-26	S	D	1,600	$20.27	72,489	D	—	—	(F2) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.